Latest updates for Biotech Startup

Fresh curated links around biotech startup are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push
  • BIRAC nurturing the biotech sector; Turning bars into classrooms
  • Prime Venture, Leo Capital back biotech startup StrainX in $13M round

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /3 weeks ago

Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push

An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.

Read source
yourstory.com /1 month ago

BIRAC nurturing the biotech sector; Turning bars into classrooms

Several successful biotech startups trace their roots to BIRAC. Cleantech company GPS Renewables, for example, received funding under BIRAC’s Biotechnology Ignition Grant.

Read source
yourstory.com /1 month ago

Prime Venture, Leo Capital back biotech startup StrainX in $13M round

Prime Venture Partners and Leo Capital lead investment as the IIT Delhi-founded startup bets on precision fermentation and bio-manufacturing for global markets.

Read source
medcitynews.com /1 month ago

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnolo...

Read source
biopharmadive.com /1 month ago

Stealthy startup Treeline plans a reverse merger

Led by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more following closely behind.

Read source
fiercebiotech.com /1 month ago

Fueled by M&A and partnerships, biotech is poised for continued growth: EY

Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum into 2026, as the volume and value of licensing and M&A deals continues to increase. N...

Read source
biopharmadive.com /21 hours ago

Braveheart, Attovia join next wave of biotech IPOs

The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum that’s already yielded several big-ticket IPOs. 

Read source
qchron.com /1 week ago

Startup Island TAIWAN Bridges Tech Hubs, Launching East Coast Biotech Initiative in Boston

BOSTON, July 5, 2026 /PRNewswire/ -- Following its success building a solid foundation on the U.S. West Coast, Startup Island TAIWAN, a national brand backed by the National Develo...

Read source
yourstory.com /1 month ago

How BIRAC is shaping India’s biotech startup ecosystem

The multipronged approach of Biotechnology Industry Research Assistance Council (BIRAC) encompassing funding, infrastructure, networks, market reach has led to expansion of biotech...

Read source
e27.co /3 weeks ago

From lab to factory floor: ChemT nets US$4M to make cell therapies easier to manufacture

ChemT Biotechnology, a US‑Singapore startup that claims it has built an “intelligence layer” for bio-manufacturing, has raised a total of US$5 million in 18 months, including a US$...

Read source
biopharmadive.com /1 week ago

Gene editing developer Scribe plots an IPO

The California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to go public in 2026.

Read source
thehindubusinessline.com /1 month ago

India's biotech push reaches an inflection point, but funding remains the missing piece

Historically, Indian pharmaceutical companies have focused on generics and services businesses, which carry lower risk and shorter development

Read source
fiercebiotech.com /1 month ago

Clinical-stage cancer biotech Treeline sees path to public markets via reverse merger

Treeline Biosciences, an under-the-radar cancer company that has raised more than $1 billion since its 2021 founding, is looking to step into the spotlight of the public market. Tr...

Read source
techcrunch.com /1 day ago

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Read source
biopharmadive.com /1 month ago

After raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets

Parabilis is teeing up the latest high-profile stock issuance in a year when biotech IPOs are averaging more than $286 million in total proceeds.

Read source
techcrunch.com /1 month ago

Triomics nabs $22M to bring oncology-specific AI to cancer centers

The Series B round was led by Battery Ventures.

Read source
biopharmadive.com /1 week ago

A PureTech startup banks $180M for a new IPF drug

Celea, backed by investors such as RA Capital and Leaps by Bayer, is making what it says is an improved version of Roche's Esbriet.

Read source
labiotech.eu /3 weeks ago

The Naming Patterns Behind 12,000 Biotech Companies

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and why it happens. The post The Naming Patterns Behind 12,...

Read source
inc.com /1 month ago

This Biotech Startup Thinks It Can Reverse Vision Loss and Cellular Aging. It’s Testing a Novel Therapy Now

The first human patient has received a dose of Life Biosciences’ sight recovery drug.

Read source
biopharmadive.com /1 month ago

Oorja, run by Acceleron veterans, launches to make new fibrosis drugs

The biotechnology startup emerged from stealth with a peptide drug it claims to have the potential to reverse lung scarring in people with idiopathic pulmonary fibrosis.

Read source
techcrunch.com /1 month ago

This young startup is taking on a fragrance industry that hasn’t changed in almost half a century

Fragrance tech company Patina announced Thursday a $2 million raise from investors, including Betaworks and True Ventures. 

Read source
biopharmadive.com /1 month ago

Parabilis sets a record with a $670M biotech IPO

The largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion...

Read source
fiercebiotech.com /3 weeks ago

Merck KGaA pledges $50M to build new cardio biotech with eye to later acquisition

Merck KGaA has committed $50 million to build a new biotech with prolific life science investor Versant Ventures, with the ultimate goal of devouring the NewCo down the line.

Read source
biopharmadive.com /1 week ago

Beyond Boston: Unlikely cities stake biotech claims

As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Biotech Startup

e27.co

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source